Η εξαγωγή ολοκληρώθηκε — 

B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

BackgroundVaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral and cellular responses upon vaccination. The ability to pre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, Kirsten Karberg, Franziska Szelinski, Jacob Ritter, Yidan Chen, Bernd Jahrsdörfer, Carolin Ludwig, Hubert Schrezenmeier, Andreia C. Lino, Thomas Dörner
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2022-04-01
Serija:Frontiers in Immunology
Teme:
RTX (rituximab)
B-cells
vaccination
SARS – CoV – 2
prediction
Online dostop:https://www.frontiersin.org/articles/10.3389/fimmu.2022.822885/full
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki